Page 1

● Allscripts announces second quarter 2021 results Second quarter GAAP diluted EPS of $ 0.15 ; non - GAAP diluted EPS of $ 0.23 , up 35 % year - over - year Generated $ 69 million of cash flow from continuing operations and $ 51 million of free cash flow in the second quarter Increasing 2021 outlook for Adjusted EBITDA and free cash flow CHICAGO - August 5 , 2021 - Allscripts Healthcare Solutions , Inc. ( Nasdaq : MDRX ) ( Allscripts ) announced its financial results for the three and six months ended June 30 , 2021 . Bookings ( ¹ ) were $ 180 million in the second quarter of 2021. This result compares with $ 164 million in the second quarter of 2020. Contract revenue backlog totaled $ 3.9 billion as of June 30 , 2021 . Second quarter 2021 revenue was $ 374 million compared with $ 369 million in the second quarter of 2020 . On a GAAP basis in the second quarter of 2021 , income from operations was $ 10 million compared with a GAAP loss from operations in the second quarter of 2020 of $ 25 million . Non - GAAP income from operations in the second quarter of 2021 was $ 33 million compared with $ 25 million in the second quarter of 2020 . GAAP net income in the second quarter of 2021 totaled $ 22 million compared with net loss of $ 8 million in the second quarter of 2020. Non - GAAP net income in the second quarter of 2021 was $ 33 million compared with $ 28 million in the second quarter of 2020 . GAAP diluted earnings per share in the second quarter of 2021 was $ 0.15 compared with loss per share of $ 0.05 in the second quarter of 2020. Non - GAAP diluted earnings per share in the second quarter of 2021 was $ 0.23 compared with $ 0.17 in the second quarter of 2020 . Adjusted EBITDA totaled $ 69 million in the second quarter of 2021 , compared with $ 54 million in the second quarter of 2020 . " In the second quarter , Allscripts continued to benefit from the actions we took to position the company on a sustainable path to improve margins , generate free cash flow and serve our clients with strategic innovations as they continue to manage through the pandemic . Our strong results enabled us to continue investing in our platforms to deliver value for our clients while at the same time maintaining disciplined cost management and returning a significant amount of capital to our shareholders , " said Paul M. Black , Allscripts Chief Executive Officer . " Looking ahead , we expect to benefit as health care providers , payors and life sciences companies shift their focus to acquiring best in class solutions from vendors that can deliver an integrated clinical and financial solution along with data and analytics that drive improved outcomes at the point of care . " 2021 Financial Outlook ( ² ) Allscripts is revising the following expectations : Adjusted EBITDA between $ 265 million and $ 275 million , an increase from the prior outlook of between $ 240 million and $ 260 million ● Free cash flow between $ 115 million and $ 125 million , an increase from the prior outlook of between $ 90 million and $ 100 million Allscripts is affirming the following expectations : Revenue of $ 1.5 billion